These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 12924244)

  • 1. [A hypothesis about anti-DNA antibody].
    Tajima Y
    Rinsho Byori; 2003 Jul; 51(7):615-26. PubMed ID: 12924244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
    Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C
    Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding characteristics of SLE anti-DNA autoantibodies to Catecholestrogen-modified DNA.
    Khan WA
    Scand J Immunol; 2006 Dec; 64(6):677-83. PubMed ID: 17083625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine binding characteristics of human autoantibodies-partial molecular characterization.
    Kumar S; Kalsi J; Bunting K; Ravirajan CT; Latchman DS; Pearl LH; Isenberg DA
    Mol Immunol; 2004 Jul; 41(5):495-510. PubMed ID: 15183928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies that bind glomeruli: cross-reactivity with bacterial antigen.
    Chowdhry IA; Kowal C; Hardin J; Zhou Z; Diamond B
    Arthritis Rheum; 2005 Aug; 52(8):2403-10. PubMed ID: 16052539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
    Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC
    Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.
    Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N
    Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies cross-reactive with DNA and cardiolipin in patients with systemic lupus erythematosus.
    Koike T; Tomioka H; Kumagai A
    Clin Exp Immunol; 1982 Nov; 50(2):298-302. PubMed ID: 7151328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of endothelial cell apoptosis by heat-shock protein 60-reactive antibodies from anti-endothelial cell autoantibody-positive systemic lupus erythematosus patients.
    Dieudé M; Senécal JL; Raymond Y
    Arthritis Rheum; 2004 Oct; 50(10):3221-31. PubMed ID: 15476243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is alpha-actinin a target for pathogenic anti-DNA antibodies in lupus nephritis?
    Mason LJ; Ravirajan CT; Rahman A; Putterman C; Isenberg DA
    Arthritis Rheum; 2004 Mar; 50(3):866-70. PubMed ID: 15022329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of singlet oxygen modified human DNA: implications for anti-DNA antibodies in systemic lupus erythematosus.
    Al Arfaj AS; Chowdhary AR; Khalil N; Ali R
    Clin Immunol; 2007 Jul; 124(1):83-9. PubMed ID: 17540620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-DNA antibodies: structure and pathogenic role].
    Ayed K
    Arch Inst Pasteur Tunis; 2000; 77(1-4):3-9. PubMed ID: 14658221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features.
    Jimenez-Boj E; Kedersha N; Tohidast-Akrad M; Karlhofer FM; Stummvoll G; Zimmermann C; Ulrich W; Guiducci S; Hoefler E; Aringer M; Schett G; Matucci-Cerinic M; Smolen JS; Steiner G
    Arthritis Rheum; 2008 May; 58(5):1226-36. PubMed ID: 18438838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lupus autoantibodies to native DNA preferentially bind DNA presented on PolIV.
    Kumar S; Bunting KA; Kalsi J; Hinks JA; Latchman DS; Pearl LH; Isenberg DA
    Immunology; 2005 Mar; 114(3):418-27. PubMed ID: 15720443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The binding of sera of patients with SLE to bacterial and mammalian DNA.
    Hamilton KJ; Schett G; Reich CF; Smolen JS; Pisetsky DS
    Clin Immunol; 2006; 118(2-3):209-18. PubMed ID: 16298553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of alpha-actinin-binding anti-double-stranded DNA antibodies with lupus nephritis.
    Renaudineau Y; Croquefer S; Jousse S; Renaudineau E; Devauchelle V; Guéguen P; Hanrotel C; Gilburd B; Saraux A; Shoenfeld Y; Putterman C; Youinou P
    Arthritis Rheum; 2006 Aug; 54(8):2523-32. PubMed ID: 16868973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to guanosine triphosphate misidentified as anti-double-stranded DNA antibodies in a patient with antinuclear antibody-negative lupus, due to buckling of insolubilized assay DNA.
    Ma CH; Hui J; Tang JT; Leung DT; Chui YL; Fok TF; Lim PL
    Arthritis Rheum; 2004 May; 50(5):1533-8. PubMed ID: 15146423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mimotopes for lupus-derived anti-DNA and nucleosome-specific autoantibodies selected from random peptide phage display libraries: facts and follies.
    Dieker JW; Sun YJ; Jacobs CW; Putterman C; Monestier M; Muller S; van der Vlag J; Berden JH
    J Immunol Methods; 2005 Jan; 296(1-2):83-93. PubMed ID: 15680153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenic role of anti-C1q autoantibodies in the development of lupus nephritis--a hypothesis.
    Flierman R; Daha MR
    Mol Immunol; 2007 Jan; 44(1-3):133-8. PubMed ID: 16870257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies against the VRT101 laminin epitope correlate with human SLE disease activity and can be removed by extracorporeal immunoadsorption.
    Amital H; Heilweil-Harel M; Ulmansky R; Harlev M; Toubi E; Hershko A; Naparstek Y
    Rheumatology (Oxford); 2007 Sep; 46(9):1433-7. PubMed ID: 17686790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.